The National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Development Center hosted the 2014 NCI SBIR Investor Forum on November 13, 2014 at Agilent Technologies in Santa Clara, CA.
Top SBIR-funded companies and nearly 200 investors, venture capitalists, strategic partners, and business leaders from the biotech and pharmaceutical industries attended featured presentations from top SBIR-funded companies with innovative cancer-related technologies on the brink of commercialization.
Relationships established at previous NCI SBIR Investor Forum events have resulted in successful partnerships that have the potential to significantly improve the prevention, diagnosis, and treatment of cancer and other diseases. This event provides a unique opportunity to establish new collaborations that will help expedite the commercialization of cancer-fighting innovations and technologies.
The NCI SBIR & Small Business Technology Transfer (STTR) Programs represent an active portfolio of more than 350 projects and an annual budget of more than $119 million. The NCI SBIR & STTR Programs are an integral source of capital that enables small businesses to move promising technologies through development and toward commercialization, and remains one of the largest sources of early stage, non-dilutive technology financing available in the United States.